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Abstract
Background/Aims: Endoplasmic reticulum (ER) stress and unfolded protein response (UPR) 
are involved in hematopoietic differentiation. However, the mechanistic linkage between ER 
stress/UPR and hematopoietic differentiation remains unclear. Methods: We used bipotent 
HL-60 cells as an in vitro hematopoietic differentiation system to investigate the role of 
ER stress and UPR activity in neutrophil and macrophage differentiation. Results: The in 
vitro differentiation analysis revealed that ER stress decreased during both neutrophil and 
macrophage differentiations, and the activities of PERK and ATF6 were decreased and that of 
IRE1α was increased during neutrophil differentiation in a stage-specific manner. By contrast, 
the activities of ATF6 and ATF4 decreased during macrophage differentiation. When the cells 
were treated with oligomycin, the expression of CD11b, a myelocytic differentiation marker, 
and morphological differentiation were suppressed, and XBP-1 activation was inhibited during 
neutrophil differentiation, whereas CD11b expression was maintained, and morphological 
differentiation was not obviously affected during macrophage differentiation. Conclusion: In 
this study, we demonstrated that neutrophil differentiation is regulated by ER stress/UPR that 
is supported by mitochondrial ATP supply, in which IRE1α-XBP1 activation is essential. Our 
findings provide the evidence that mitochondrial energy metabolism may play a critical role 
in neutrophil differentiation.
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IntroductionProtein synthesis occurs in ribosomes present in cells. Following production, these proteins are transported into the endoplasmic reticulum (ER) where they are folded into their tertiary structure. When misfolded proteins are accumulated in the ER, it causes an overload of mutant or denatured proteins. This event can lead to cell damage or apoptosis, which is known as “ER stress.” However, cells can adapt to ER stress via the unfolded protein 
response (UPR), which consists of three signaling pathways via ER-stress sensors, IRE1α, PERK, and ATF6. Once UPR is triggered by ER stress, misfolded proteins are eliminated by three mechanisms, such as producing chaperones to promote protein folding, inhibiting mRNA translation, and inducing unfolded protein degradation (ER-associated degradation; ERAD) [1, 2].On the other hand, ER stress and UPR are involved in several cellular differentiations [3]. For example, during adipocyte and B-cell differentiation, ER stress increased and Xbp-
1 splicing was induced through IRE1α activation [4]. When XBP1 activation was inhibited by blocking the supply of mitochondrial ATP through the knockdown of adenylate kinase 2 (AK2), an adenine nucleotide converting enzyme in the mitochondrial intermembrane 
space, adipocyte and B-cell differentiation was impaired [4]. Additionally, Xbp-1 knockout in mice shows impaired eosinophil differentiation [5]. However, the molecular mechanism linking ER stress/UPR, ATP supply, and cell differentiation remains unclear.
Here we studied the cell-specific roles of ER stress and UPR activity during neutrophil and macrophage differentiation with the in vitro hematopoietic differentiation system using the bipotent myeloid cell line HL-60.
Materials and Methods
Cell culture and differentiationsHL-60 human promyelocytic leukemia cells were provided by the RIKEN BioResource Center through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science, and Technology, 
Japan [6, 7]. HL-60 cells were maintained in RPMI-1640 medium with 10% fetal bovine serum (FBS). Neutrophil differentiation was induced by treating HL-60 cells (2.5 × 105 cells/ml) with 10 μM all-trans 
retinoic acid (ATRA) (Sigma, St. Louis, MO) in a flask [8]. Macrophage differentiation was induced by treating HL-60 cells (1 × 105 cells/ml) with 20 nM phorbol myristate acetate (PMA) (Sigma) in a 6-well plate [9].
ReagentsTo reduce ER stress induced by misfolded proteins, HL-60 cells (2.5 × 105 cells/ml) were treated with 
0.67, 2, 6 mM of 4-phenylbutyric acid (4-PBA) (Sigma), a chemical chaperone, in a flask for 4 days. For UPR 
inhibition, we used the following compounds: 4-(2-aminoethyl)benzenesulfonylfluoride (AEBSF) (02068-
64; NACALAI TESQUE, Kyoto, Japan) as ATF6 inhibitor, GSK2606414 (G7345; LKT laboratories, St. Paul, MN) 
as PERK inhibitor, and 8-formyl-4-methylumbelliferone (4μ8C) (4479/10; R&D Systems, Minneapolis, MN) 
as IRE1α-XBP1 inhibitor. To inhibit mitochondrial ATP production, we used oligomycin (#11341; Cayman 
Chemical, Ann Arbor, MI). As a positive control, we applied 0.6 μg/ml of tunicamycin to the HL-60 culture 
for 8 h to induce ER stress.
Western blotWestern blot analyses were performed as previously described [10]. For electrophoresis, we used 
20 μg of sample protein. After subsequently transferring the proteins to PVDF membranes and applying 
a nonspecific epitope blocking using 5% skimmed milk, the following antibodies were applied for 1 h or 
overnight: human integrin alpha M/CD11b (238439) (R&D systems), anti-XBP1 antibody (ab37152; Abcam, 
Cambridge, MA), CREB-2 antibody (C-20) (cs-200; Santa cruz, Santa Cruz, CA) as ATF4 antibody, anti-ATF6 
antibody (ab37149; Abcam, and sc-166659; Santa Cruz), anti-caspase-3 antibody (9662S; Cell Signaling 
Technology, Danvers, MA) and monoclonal anti-β-actin Clone AC-15 (Sigma) as a loading control. ECL anti-
rabbit IgG horseradish peroxidase-linked whole antibody and anti-mouse IgG (GE Healthcare, Munich, 
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Germany) were used as secondary antibodies. Immunodetection signals were identified using Immobilon 
Western Chemiluminescent HRP Substrate (Millipore, Billerica, MA) and exposed to Fuji medical X-ray film 
(Fujifilm, Tokyo, Japan).
Wright-Giemsa staining
Cells were analyzed by staining with Wright-Giemsa solution (Muto Pure Chemicals, Tokyo, Japan) 
according to the manufacturer’s protocol. Briefly, cells were smeared on glass slides manually or prepared 
by CytoSpin4 Cytocentrifuge (Thermo Fisher Scientific, Waltham, MA). Then, they were dried and stained 
with Wright-Giemsa solution for 2 min. After diluting M/150 phosphate buffer, cells were stained for 8 min and were then washed.
NBT assayCells (6 × 105 cells) were incubated with NBT solution (Muto Pure Chemicals, Tokyo, Japan) for 30 min at 37°C. Then, the cells were suspended in PBS, and NBT-positive cells (about 100 cells) were counted, and calculated the ratio of NBT positive cells to the total number of cells.
Apoptosis analysis
Apoptotic cells were counted by ~ 55 fields in each slide with Wright-Giemsa staining, and the apoptotic rate was calculated as the percentage of apoptotic cells to total cells.
Measurement of intracellular ATP amount
ATP content was measured using CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, 
WI) according to the manufacturer’s instruction. Briefly, 100 μl of the cell culture was transferred into a 
black 96-well dish, and the same amount of CellTiter-Glo reagent was added into the wells. After shaking the plate for 30 s and leaving it to rest for 10 min, the amount of ATP in the well was measured using Tristar 
LB 941 luminometer (Berthold Japan, Tokyo, Japan). Each value was normalized by total protein amount.
StatisticsEach analysis was performed in triplicate, and all experiments were conducted under the same 
experimental conditions. We used the Image J software (http://rsb.info.nih.gov/ij/) to quantify the western 
blot data. The data were normalized by β-actin content. Graphs show means ± SD. Student’s t-test was performed in Microsoft Excel 2010 and a P-value of <0.05 was considered as statistically significant.
Results
ER stress levels during hematopoietic differentiation of HL-60 cellsHL-60 cells can differentiate into neutrophils or macrophages by ATRA or PMA, respectively. To explore the role of ER-stress and UPR in the myeloid differentiation of HL-
60 cells, we first examined the expression of BiP, an ER stress marker, using western blot analysis. BiP expression was elevated in non-treated HL-60 cells and reduced during both ATRA-induced neutrophil differentiation and PMA-induced macrophage differentiation 
(Fig. 1). In neutrophil differentiation, BiP expression on day 4 remained at approximately 
10% of that on day 1. During macrophage differentiation, we also observed reduction in BiP 
expression to that on day 1. We confirmed that neutrophil and macrophage differentiation 
is completed at days 4 and 1, respectively, based on morphological changes and marker expressions as shown previously [11]. Thus, we found the reduction in ER stress marker expression during myeloid differentiation in our system. Then we evaluated the effect of ER 
stress on neutrophil differentiation in HL-60 cells. HL-60 cells were treated with 4-PBA, a chemical chaperone, which reduces ER stress [12], and assessed ER stress level by BiP and 
differentiation by CD11b differentiation marker. 4-PBA treatment reduced ER stress marker expression dose-dependently, and concomitantly both up-regulation of CD11b expression 
and nuclear morphological changes were observed with 2mM of 4-PBA (Fig. 1c, d). These results suggested that neutrophil differentiation is controlled by ER stress level.
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Fig. 1. Expression level of the ER-stress marker BiP in HL-60 cells following ATRA and PMA treatments. (a) Dynamic change in ER stress during neutrophil and macrophage differentiation. BiP expression was detect-
ed as a marker of ER stress using BiP antibody. #1 and #2 represent different samples. β-actin is shown as a loading control. (b) Relative BiP expression level. Data of western blot analysis in (a) are represented using graphs. The relative ratio is calculated using the value of non-treated HL-60 cells (NT) as 1. Tu indicates the 
samples of HL-60 cells treated with tunicamycin (0.6 μg/ml, 8 h) as a positive control. N = 3. ** P<0.01, *** 
P<0.001. (c) HL-60 cells were treated with 4-PBA at the doses indicated in the Fig. CD11b expression was 
detected as a marker of myeloid differentiation. Cells treated with 6 mM of 4-PBA for 2, 3, and 4 days were 
dead; thus, β-actin signals were not detected. (d) Wright-Giemsa staining was performed with cells treated 
with or without 4-PBA for 4 days. Cells treated with 6 mM of 4-PBA were not shown because of cell death. Arrowheads, segmented neutrophils.
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UPR activity during differentiation in HL-60 cellsNext, we further analyzed UPR activity in response to ER stress dynamics in neutro-phil and macrophage differentiation. Before inducing differentiation, we found that two UPR 
pathways were activated by detecting cleaved ATF6 and ATF4 in HL-60 cells (Fig. 2). This 
finding was consistent with BiP expression in non-treated HL-60 cells (Fig. 1), suggesting that ER stress is constantly present in bipotent HL-60 cells and that UPR in response to ER stress may help to maintain cellular homeostasis and cell survival. Following ATRA treat-
ment, the uncleaved and cleaved forms of ATF6 and ATF4 expressions decreased gradually 
during neutrophil differentiation and the spliced XBP1 came out at day 4 (Fig. 2). By con-trast, only the uncleaved and cleaved forms of ATF6 were observed at low level following PMA treatment for macrophage differentiation.
Essential role of UPR activity in neutrophil differentiation of HL-60 cells
Because cell-type specific UPR responses were observed, we further investigated the 
effect of UPR inhibition on neutrophil and macrophage differentiation (Fig. 3). At first, we 
Fig. 3. Effect of UPR inhibitors on neutrophil and macrophage differentiation. (a) Effects of UPR inhibitors on the activation of each UPR pathway, which were evaluated by western blot analysis. Samples were treated with or without tunicamycin as an ER stress inducer. D indicates dimethyl sulfoxide (DMSO). NT shows non-treated HL-60 cells. (b) Effects of each UPR inhibitor on myeloid differentiation. CD11b expression was 
evaluated by western blot analysis at day 1 of macrophage differentiation and day 4 of neutrophil differen-tiation. D represents HL-60 cells treated with DMSO (vehicle) and PMA or ATRA in (b). (c) Relative CD11b expression levels with UPR inhibitors. Data of western blot analysis in (b) are represented using graphs. The relative ratio is estimated using the value of ATRA-treated or PMA-treated HL-60 cells without UPR inhibitor 
treatment as 1. β-actin is shown as a loading control. (d) Morphological confirmation of neutrophil and mac-
rophage differentiation by Wright-Giemsa staining. The concentrations of inhibitors were GSK 9μM, 4μ8C 
10μM, and AEBSF 30μM. Scale bar, 100 μm. Arrowheads, segmented neutrophil; asterisks, apoptotic cell. (e) Functional assessment using NBT assays. Mature differentiated macrophage- and neutrophil-like HL-60 
cells are NBT positive. GSK2606414 (GSK), PERK inhibitor; 4μ8C, IRE1α inhibitor; AEBSF, ATF6 inhibitor. N 
= 3. * P<0.05, ** P<0.01, *** P<0.001 v.s. ATRA or PMA.
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examined the effects of UPR inhibitors (GSK2606414 (GSK) for PERK, 4μ8C as IRE1α-XBP1 
inhibitor, and AEBSF as ATF6) by applying them to HL-60 cells. Each inhibitor specifically inactivated the corresponding URP pathway (Fig. 3a). Next, we examined the effects of UPR inhibitors on the expression of CD11b, a myelocytic differentiation marker, during myeloid differentiation by western blot analysis (Figs. 3b and 3c). CD11b expression decreased with all UPR inhibitors during neutrophil differentiation.
Next, we checked cell morphology by Wright-Giemsa staining, and function by NBT assay. ATRA- and (ATRA+DMSO)-treated cells had segmented and band nucleus like mature 
neutrophil (Fig.3d). In ATRA + GSK treatment, nuclear/cytoplasmic ratio was decreased, and 
almost cells represented segmented or band nucleus. In ATRA + 4μ8C treatment, segmented nuclear cells were few, and many cells were myelocyte-like which had rounded nucleus, and metamyelocyte-like which had kidney-shaped nucleus. In ATRA+AEBSF treatment, some cells could differentiate into segmented- or band-neutrophils. But, there seemed to be fewer 
mature differentiated cells than by GSK treatment. For cellular function, all UPR inhibitors 
reduced NBT-positive cells to 60 - 70 % of ATRA treatment (71 % in GSK, 65 % in 4μ8C, 64 
% in AEBSF).
Fig. 4. Effect of UPR inhibitors and oligomycin on apoptosis in neutrophil and macrophage differentiation. 
Apoptosis signal was evaluated by the apoptotic rate (% of total cells) (a, b) and cleaved caspase-3 level (c 
- e) at day 4 of neutrophil differentiation and day 1 of macrophage differentiation. (a, b) Cells were stained 
with Wright-Giemsa and counted. The apoptotic rate was calculated. N.D., not detected. (c - e) Cleaved cas-
pase-3 was detected as a marker of apoptosis. β-actin is shown as a loading control. HL-60 cells treated with 
50 μM etoposide for 4 h were used as positive control. NT, non-treated HL-60 cells; D, HL-60 cells treated with DMSO (vehicle) and ATRA or PMA. Asterisks, full length caspase-3; arrowheads, cleaved Caspase-3. 
(e) Relative cleaved caspase-3 levels with UPR inhibitors in neutrophil differentiation. Graph is prepared with densitometric analysis of the data of western blot with ATRA and UPR inhibitors shown in (c). The 
concentrations of inhibitors were GSK 9 μM, 4μ8C 10 μM, AEBSF 30 μM. * P<0.05, ** P<0.01, *** P<0.001 v.s. ATRA + D.
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Furthermore, apoptotic cells were characterized by cell shrinkage and chromatin condensation that were found i n treatments with ATRA alone or ATRA + UPR inhibitors (Fig. 
3d). We found that ATRA induced apoptosis (7 % of total cells) in Fig. 4a. In UPR inhibitor 
treatment, 4μ8C and AEBSF enhanced apoptosis in neutrophil differentiation significantly 
(17.9 % and 23.8 %). In contrast, ATRA + GSK treatment seemed to decrease apoptosis ratio 
(3.4%) compare to ATRA + DMSO treatment (8.4 %). Consistent with these findings, the 
statistically significant increase of an apoptotic marker, cleaved caspase-3 was observed by 
4μ8C and AEBSF treatment in neutrophil differentiation (Fig. 4c, e).In the case of PMA treatment, no inhibitor blocked macrophage differentiation as shown 
by CD11b surface marker expression and morphology (Fig. 3b, c, d). In NBT assay with GSK 
treatment, NBT-positive cells were reduced slightly (85%) in each differentiation (Fig. 3c, 
e). Additionally, PMA did not induce apoptosis as shown in Fig. 4. These findings clearly demonstrated that surface marker expression, cell shape, and cellular function are regulated through UPR during neutrophil differentiation. In contrast, UPR may not be important for macrophage differentiation. In other words, while hematopoietic precursor HL-60 cells are released from ER stress during neutrophil or macrophage differentiation, cell-lineage 
specific UPR activation is required for neutrophil differentiation.
Effects of inhibition of mitochondrial ATP production on myelocytic differentiation
Because both ER stress sensing and URP activation require ATP [1, 2, 13], we next analyzed whether ATP synthesis inhibition has effects on myelocytic differentiation using oligomycin, an inhibitor of mitochondrial ATP supply (Figs. 5 and 6).
Oligomycin significantly reduced mitochondrial ATP production to one-tenth and half during neutrophil and macrophage differentiation compared with ATRA- or PMA-treated 
cells, respectively, whereas no significant difference was observed between ATRA or PMA 
Fig. 5. Inhibitory effect of ATP production by oligomycin during neutrophil and macrophage dif-ferentiation. (a) ATP production during neutrophil differentiation with and without oligomycin. (b) ATP production during macro-phage differentiation with and without oligomycin. The relative value is normalized with protein amounts. The tables in (a) and (b) show the percentages of ATP production compared with either ATRA- or PMA-treated cells, which 
was taken as 100 %. NT, non-treat-ed; A, ATRA; P, PMA; O, oligomy-
cin. *, † P<0.05, **, †† P<0.01, ***, 
††† P<0.001. Asterisk(s), v.s. NT; dagger(s), v.s. ATRA.
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treatment with and without DMSO (Fig. 5). CD11b expression also markedly decreased during neutrophil and macrophage differentiation (Fig. 6). Interestingly, the reduction in CD11b expression was higher during neutrophil differentiation than during macrophage differentiation (Fig. 6b). Additionally, in morphological analysis as shown in Fig. 6c, oligomycin inhibited neutrophil differentiation at the stage of promyelocyte and resulted in inducing cell death. However, apoptosis rate was dose-dependently reduced by oligomycin 
treatment and cleaved Caspase-3 was not detected (Fig. 4b, d, e).By contrast, many cells treated with PMA plus oligomycin could differentiate into macrophage (Fig. 6b). But apparent apoptosis was not detected in PMA treated cells by 
Wright-Giemsa staining and cleaved caspase 3 was also not detected by western blot analysis. 
These findings indicate that reduction in mitochondrial ATP production significantly 
influences neutrophil differentiation, but not macrophage differentiation, suggesting that mitochondrial ATP synthesis is essential for neutrophil differentiation.
Based on these findings, we further examined the role of mitochondrial ATP in UPR during myelocytic differentiation. We tested whether UPR is inhibited by oligomycin treatment. In 
neutrophil differentiation, ATF6 and PERK-ATF4 were not affected by oligomycin treatment 
at day 1 (Fig. 7). However, XBP-1 activation was abolished by oligomycin at day 4 of ATRA treatment. Moreover, BiP expression was increased in oligomycin-treated HL-60 cells at the same level as that in non-treated HL-60 cells. Thus, these results indicate that ATP depletion 
by oligomycin inhibited neutrophil differentiation via the impairment of IRE1α-XBP1 
Fig. 6. Effect of ATP depletion by oligomycin on neutrophil and macrophage differentiation (a) CD11b ex-pression during neutrophil and macrophage differentiation with and without oligomycin. CD11b expression 
was analyzed at day 4 for ATRA treatment and at day 1 for PMA. (b) Relative ratio of CD11b expression in (a). The relative ratio is normalized using “D” as 1. O, Oligomycin; NT, non-treated; A, ATRA; D, inducer + 
DMSO. * P<0.05; **, ## P<0.01; ***, ###, †††, P<0.001. Asterisk(s), v.s. ATRA + D; dagger(s), v.s. PMA + D. (c) 
Morphological confirmation of oligomycin effects on neutrophil and macrophage differentiation by Wright-
Giemsa staining. Scale bar, 100 μm.
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activation and induced high ER stress at the similar level to that in non-treated HL-60 cells. 
In macrophage differentiation, ATF6 expression was not significantly affected by oligomycin treatment. BiP expression was increased by oligomycin, but it was not as high as that in non-treated HL-60 cells.
DiscussionIn this study, we examined the functional link between ER stress/UPR and hematopoietic differentiation in vitro using bipotent HL-60 cells. Specifically, we focused on the relationship 
between ATP supply from mitochondria and ER stress/UPR. Our findings on ER stress/UPR 
dynamics during neutrophil and macrophage differentiation are summarized in Fig. 8.
ER stress as a regulator in neutrophil and macrophage differentiationUnder a standard culture condition, HL-60 cells highly expressed BiP, a marker for ER stress. As shown in Fig. 1, BiP expression was reduced to a minimum level during neutrophil differentiation, whereas it nearly completely disappeared during macrophage differentiation. 
These findings suggested that ER stress might inhibit myeloid differentiation. Consistent with 
these findings, 4-PBA, a chemical chaperone [12], was found to induce CD11b expression and morphological differentiation with reciprocal decrease in BiP expression, demonstrating 
that reduction of ER stress is required for HL-60 cell differentiation (Fig. 1c, d). Intriguingly, 
Fig. 7. Effect of ATP depletion by oligomycin on UPR expression dur-ing neutrophil and macrophage differentiation. (a, b) Inhibition of UPR pathways (ATF6, PERK, 
and IRE1α) during neutrophil and macrophage differentiation by oli-gomycin. Cleaved ATF6 represents 
marker for ATF6 activation, ATF4 for PERK activation, and spliced 
XBP-1 (sXBP-1) for IRE1α-XBP1 
pathway activation at day 4 for ATRA treatment (a) and at day 1 for PMA (b) by western blot analy-
sis. β-actin is shown as a loading control. Data of western blot analy-sis are represented using graphs. 
Except for ATF4 in neutrophil dif-ferentiation, the relative ratio is estimated using the value of ATRA-treated or PMA-treated HL-60 cells 
as 1. Data of ATF4 in neutrophil differentiation are shown as values 
divided by β-actin because the val-
ue of ATF4 in ATRA-treated HL-60 was zero, which could not be used to estimate data. NT, non-treated; A, ATRA; P, PMA; D, DMSO (vehicle of oligomycin) with ATRA or PMA; 
O, oligomycin. N = 3. * P<0.05, ** 
P<0.01, *** P<0.001.
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morphological analyses shown in Fig.1, 3 and 6 revealed that 4-PBA-treatment induced partial differentiation of neutrophil such as myelocyte, metamyelocyte, and a few of segmented neutrophil, compared to the cells treated with ATRA only, showing more matured neutrophil with segmented and band nucleus. From these results, maturation arrest of HL-60 might be caused by not only impairment of ER stress-UPR axis but also unknown disturbance of 
metabolic regulation that is restored by retinoic acid. Taken together, based on our findings, we thought that high ER stress levels in undifferentiated HL-60 cells could function as a 
negative regulator for myeloid differentiations (Fig. 8).
Lineage-specific UPR activation in myelocytic differentiation
During neutrophil differentiation of HL-60 cells, both cleaved ATF6 and ATF4 expressions were reduced to minimum levels at the early differentiation phase and activation 
of XBP1 expression occurred at the later phase (Fig. 2). On the other hand, in macrophage 
differentiation, cleaved ATF6 expression was reduced to minimum levels, whereas ATF4 
expression was lost and XBP-1 was not activated. About the reduction of uncleaved ATF6, it has been reported that ER stress regulates expression of ATF6 mRNA through cleaved 
ATF6 level [14]. Therefore, it was thought that decreased ER stress reduces cleaved ATF6 level, and then suppress full length ATF6 protein expression through regulating its mRNA 
expression. Importantly, our findings suggested that lineage-specific UPR activity is required 
during myeloid differentiation, which is consistent with the findings in previous studies on hematopoietic differentiation [5, 15, 16].For neutrophil differentiation, all UPR inhibitors used in this study inhibited neutrophil differentiation (Fig. 3), and blocking of mitochondrial ATP synthesis by oligomycin impaired 
Fig. 8. Hypothetical model of a functional link between bioenergetics and ER stress/UPR in un-differentiated and myeloid-differentiating states of HL-60 cells (Upper part) In non-treated HL-60 cells, ATP production relied on glycolysis. The low ATP supply from mitochondria (mito ATP) promotes high ER stress, as evidenced by strong BiP expression, causing impairments in BiP acti-vation and protein folding. High ER stress level impairs myeloid differentiation. However, ATF6 and PERK, which can function under the con-dition of low ATP amount, may support HL-60 cell survival against high ER stress. (The lower right part) During neutrophil differentiation in response to ATRA, mitochondrial ATP supply 
by OXPHOS increases through unknown mecha-
nism. Subsequently, higher ATP supply from mi-tochondria triggers the following two responses: 1) Reduction in ER stress, which possibly occurs by increased BiP activation due to increased ATP supply; reduced ER stress then reduces ATF6 
and PERK-ATF4 activity. 2) XBP-1 activation via IRE1α, which requires more ATP for its own activation. 
Both PERK-ATF4 and ATF6 activation levels decrease at the early stage, whereas XBP1-spliced form level increases at the late stage of neutrophil differentiation. Thus, during differentiation, HL-60 cells released 
from ER stress acquire the ability to differentiate step-by-step, and activated XBP-1 specifically leads to the neutrophil differentiation of HL-60 cells. (The lower left part) On the other hand, during macrophage differ-entiation after PMA treatment PKC signal may induce the reduction in ER stress by unknown mechanism(s). In macrophage differentiation, ATP may be supplied mainly from glycolysis. Mitochondrial ATP production may be similar to that in undifferentiated HL-60 cells. Both reduction in ER stress and induction of key factor(s) by PKC signal may trigger macrophage differentiation in HL-60 cells.
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neutrophil differentiation via the inhibition of XBP-1 activation (Figs. 6 and 7). These results 
suggest that UPR activations, especially that of XBP-1, through mitochondrial ATP supply is critical for neutrophil differentiation.
In addition, we found the unique switching profile of UPR from reducing ATF6 and PERK 
expression at the early phase of neutrophil differentiation to increasing XBP-1 expression at 
the late phase (Fig. 2). Consistent with these findings, a previous study demonstrated that ATF6 increases unspliced Xbp-1 mRNA and that PERK-ATF4 cascade increases IRE1α expression; 
thus, both ATF6 and PERK may promote XBP-1 activation [17]. Therefore, together with our experimental data, we hypothesize that the integration mechanism of two UPR pathways of 
ATF6 and PERK lead to the enhancement of XBP-1 activation, which is critical for neutrophil 
differentiation (Fig. 8). However, this scenario remains to be determined.
Previous studies demonstrated that XBP-1 expression was related to hematopoietic 
differentiation [5, 18]. Bettigole et al. demonstrated that eosinophil differentiation failed in 
Xbp-1-KO mice, while neutrophil differentiation was not affected [5]. However, Shen et al. argued that the functional differentiation of neutrophil in Xbp-1-KO mice was not determined 
[18]. In addition, Bettigole et al. checked CD11b+Ly6G+ cells as differentiated neutrophils in 
Xbp-1-KO mice [5]. However, both differentiation markers (CD11b and Ly6G) are expressed from the early stage (promyelocyte) to the late stage (matured neutrophil) in neutrophil 
differentiation [19]. Consequently, it was suggested that CD11b+Ly6G+ cells do not fully differentiate into mature neutrophils. In our previous study, we demonstrated that HL-60 cells treated with ATRA in vitro for 4 days functionally differentiated and showed phagocytic 
activity and NBT-reducing capacity [11]. Therefore, we believe that XBP-1 may be essential at the late stage of neutrophil differentiation to become functionally matured neutrophils.In contrast to neutrophil differentiation, macrophage differentiation was not inhibited 
by any UPR inhibitors (Figs. 3b and 3c). However, ER stress was significantly reduced during 
macrophage differentiation (Fig. 1). These findings suggested that ER stress regulates macrophage differentiation similar to neutrophil differentiation and that ER stress is 
controlled by other systems but not UPR. Further studies are required to prove the hypothesis and identify key endogenous player(s) of macrophage differentiation in ER stress reduction. These players may be downstream targets of PKC and independent of UPR.
Importance of ATP supply from glycolysis and mitochondrial oxidative phosphorylation 
(OXPHOS)During neutrophil differentiation, ATP production was decreased gradually in ATRA- 
and (ATRA+DMSO)-treated cells compared to non-treated cells. This finding was consistent with the previous reports, in which ATP production in neutrophil-differentiated HL-60 cells was shown to be lower than in undifferentiated HL-60 cells [20].
Another interesting finding is the functional link between ATP source and cellular differentiation through ER stress and UPR regulation. Protein folding steps supported by 
chaperone activity require ATP [21, 22]. Furthermore, BiP, a chaperone and an ER stress sensor, also needs ATP for its activation [1, 23]. A previous study demonstrated that the 
inhibition of ATP utilization with 2-deoxy-D-glucose increased ER stress [24]. For UPR, 
IRE1α has an ATP-binding pocket, which requires ATP for its activation [1, 2]. PERK also 
requires ATP for its activation [25]. On the other hand, ATF6 does not have any ATP-binding sites [2], and no relationship between ATF6 and ATP has been reported.
The cells obtain ATP through glycolysis and/or OXPHOS. Haga et al. demonstrated a possible link between mitochondrial ATP production and UPR activation under glucose deprivation [26]. As shown in Figs. 5 and 6, we demonstrated that neutrophil and macrophage 
differentiation relies on ATP production from mitochondrial OXPHOS in varying degrees. 
We found that intracellular ATP contents were significantly decreased during neutrophil differentiation in the presence of oligomycin in a dose-dependent manner. Application 
with 3 μM of oligomycin reduced ATP content by approximately 90% after ATRA treatment 
(Fig. 5a). On the other hand, ATP content decreased by about 40% after adding 0.3 μM of oligomycin, although higher doses did not further reduce ATP content during macrophage 
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differentiation (Fig. 5b). High mitochondrial dependency was observed during neutrophil, but not macrophage differentiation. Consistent with these observations, a previous report 
demonstrated that HL-60ρ0 cells, in which mitochondria are depleted and only glycolysis is 
the ATP source, could differentiate into macrophages but not neutrophils [27]. These findings 
indicated that ATP for ER stress/UPR, especially XBP1 activation, is mainly supplied from 
mitochondria for neutrophil differentiation, whereas glycolysis-derived ATP is sufficient for 
macrophage differentiation (Fig. 8). For neutrophil differentiation, BiP chaperone could be 
activated by mitochondrial ATP supply, and protein folding may proceed smoothly (Fig. 8, 
right lower part). IRE1α activation could also occur by ATP supply to support neutrophil differentiation. However, it is essential to clarify how ATRA increases mitochondrial ATP 
production (mito ATP). In contrast, ATP supplied from glycolysis was sufficient to induce 
macrophage differentiation of HL-60 cells (Fig. 8, left lower part). One possible explanation 
for different ATP demand between macrophage and neutrophil differentiation is that IRE1α 
activation requires relatively higher ATP amounts than PERK activation. PERK may be 
activated with low level of ATP supplied from glycolysis. On the other hand, IRE1α may need 
high ATP amounts which derived from mitochondrial OXPHOS. It is essential to determine the ATP sensitivity of each UPR pathway to develop small chemical molecules targeting each UPR activity.
UPR-requirement for cell survival during neutrophil differentiation
As shown in Fig. 3d and Fig. 4, apoptotic cells were detected with ATRA or ATRA plus UPR 
inhibitor treatment. However, they were not detected in ATRA + 3μM oligomycin or PMA-treated groups. The apoptotic percentage in ATRA-treated cells increased to approximately 
7.5 %. Retinoic acid has been reported to induce extrinsic apoptosis mediated by TRAIL 
induction and subsequent caspase-3 activation [28, 29]. In addition, caspase-independent apoptosis mediated by calpain was also reported in human neutrophil [30]. As shown in 
Fig. 4c to e, cleaved caspase 3 was hardly detected in ATRA-treated cells as the same as non-treated cells, suggesting that ATRA-induced apoptosis is mainly caused by caspase-3 independent. These data suggested that ATRA-induced apoptosis in HL-60 cells might be through calpain as a possible mechanism.
Intriguingly, we observed increased apoptosis specifically by AEBSF and 4μ8C, but not 
GSK, in the analysis of HL-60 cells treated with ATRA plus UPR inhibitors (Fig. 4a). These 
findings indicated that blocking the UPR signals may increase apoptosis of HL-60 cells through enhancing ER-stress. In other words, UPR signals are critical for cell survival.UPR has two modes. One is survival pathway through enhancement of chaperones or ERAD in response to mild ER stress, and other is apoptotic pathway through CHOP/caspase-3 
and ATG proteins in response to severe/chronic ER stress [31-35]. Fig. 1 showed that the BiP level was reduced during neutrophil differentiation, indicating that ER stress was mitigated, and Fig. 2 indicated the switching of the UPR pathway in neutrophil differentiation from 
PERK and ATF6 in the early phase to IRE1α-XBP1 in the late phase. These findings suggested 
that ATRA-induced neutrophil differentiation of HL-60 cells requires activation of all UPR pathways to reduce ER stress and to survive. Therefore, treatment with UPR inhibitors was meant to increase ER stress, thereby it was thought that apoptosis was enhanced. In summary, UPR has a critical role in survival of HL-60 cells by reducing ER stress during neutrophil differentiation. However, we need study to further dissect the roles of phase-dependent multifaceted UPR signals for cell survival during ATRA-induced neutrophil differentiation.Additional interesting phenomena are as follows; PMA did not induce apoptosis, and oligomycin inhibited ATRA-induced apoptosis. First, in a previous study, PMA treatment showed the reduced apoptotic rate compared to HL-60 cells treated with thapsigargin, 
an ER stress inducer, or 4-bromo-calcium ionophore at the similar level to untreated HL-60 cells [36]. It was demonstrated that PMA treatment could induce and activate Bcl2 family members including Mcl1 that are associated to anti-apoptotic activity through PKC activation [37-39]. However, the detail mechanisms remain unclear, so we need to further clarify. Second, oligomycin reduced ATRA-induced apoptosis. It has been also reported that 
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regulation of cell death types, either apoptosis or necrosis, is depending on intracellular ATP 
level. We observed that oligomycin treatment significantly reduced cellular ATP amounts by inhibiting mitochondrial ATP production and it concomitantly reduced apoptotic rate as 
shown in Fig. 4 and Fig. 5a. This finding clearly demonstrates the importance of mitochondria linking energy metabolism and ER stress/UPR in ATRA-induced neutrophil differentiation.
Relationship between ER stress/UPR and hematopoietic diseases with differentiation 
arrestPrevious reports on congenital neutropenia have suggested a link between ER stress/
UPR, mitochondrial ATP production, and neutrophil differentiation [40-44]. UPR dysfunction and increased ER stress occur in cells with a mutation of the elastase, neutrophil expressed (ELANE) gene, which encodes an abnormal neutrophil elastase (NE), impairing neutrophil 
differentiation [40, 41]. Additionally, mutation of the ubiquitous glucose-6-phosphatase subunit a gene (G6PC3) also leads to neutrophil defects. This mutation affects protein glycosylation by increasing ER stress by compromising glycosylation without increasing 
serum glucose concentration [42, 43]. These reports suggested that both maintaining UPR and controlling ER stress are important for neutrophil differentiation in a stage- and 
intensity-specific manner. Regarding the stage-specific activation of UPR, spliced XBP-1 was 
induced during B-cell differentiation using LPS stimulation [44]. Furthermore, in reticular dysgenesis (RD) (OMIM #267500, http://www.omim.org/entry/267500), the myeloid 
precursor cells with AK2 deficiency cannot produce ATP in mitochondria, resulting in defective ATP transport from the mitochondria to the ER during neutrophil differentiation. 
Therefore, in AK2-deficient myeloid precursor cells, IRE1α-sXBP1 activation might be 
impaired through an insufficient mitochondrial ATP supply. As a consequence, abnormal ER stress and UPR dysfunction could block neutrophil differentiation in RD patients, such as that shown in patients with neutropenia due to ELANE mutation [40, 41]. In contrast, macrophage differentiation can be maintained by ATF6 activation even in the absence of 
mitochondrial ATP supply because ATF6 activation does not require ATP.
Conclusion
In this study we demonstrated that stage-specific regulation of ATF6, PERK, and IRE1α activation occurs during neutrophil differentiation of HL-60 cells and that mitochondrial 
ATP supply may be essential for IRE1α activation. Therefore, myeloid precursor cells 
may reduce ER stress during both macrophage and neutrophil differentiation, and XBP-1 
activation may promote neutrophil differentiation. Only ATF6, which does not require ATP, 
was activated for macrophage differentiation. Because sufficient ATP can be supplied from 
glycolysis, energy homeostasis can be maintained without OXPHOS during macrophage differentiation. In conclusion, we demonstrated a close correlation between mitochondrial 
ATP production and neutrophil differentiation through stage-specific activation of UPR 
branch, such as XBP-1, and reduction in ER stress. However, our study did not demonstrate how ATRA and PMA control the switching of cell fate through ATP supply from glycolysis or mitochondria. Further, the detailed molecular mechanisms of myeloid differentiation 
through reduced ER stress and UPR activation is still unclear. Further studies are required to 
solve these pertinent questions, which will provide the target to develop new therapies for mitochondrial diseases, such as reticular dysgenesis.
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